Earnest Partners reports 5.4% stake in Inspenity
Inspenrity, Inc. Schedule 13G filing reports that Earnest Partners, LLC beneficially owns 2,066,472 shares of Inspenity common stock, representing 5.4% of the class as reported.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Inspenrity, Inc. Schedule 13G filing reports that Earnest Partners, LLC beneficially owns 2,066,472 shares of Inspenity common stock, representing 5.4% of the class as reported. The filing shows 1,519,215 shares with sole voting power and 389,802 shares with shared voting power. The filing is submitted by Earnest Partners as an investment adviser under applicable SEC rules.
Insights
Earnest Partners holds a 5.4% position in Inspenity.
The filing lists 2,066,472 shares beneficially owned, with sole dispositive power over that amount. This indicates Earnest Partners controls voting/disposition for the reported position as an investment adviser.
Timing and client-level details are not provided; subsequent disclosures could show changes if clients direct different actions.
Key Figures
Key Terms
Schedule 13G regulatory
Beneficially owned financial
Sole dispositive power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Earnest Partners report in INSP?
Is Earnest Partners filing as an investment adviser for INSP?
Who signed the Schedule 13G for Earnest Partners?
Where are Inspenity's principal executive offices listed?
AI-generated analysis. How Rhea-AI works. Not financial advice.